- Home
- BARK vs OLMA Comparison
BARK vs OLMA Comparison
Compare BARK & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- OLMA
- Stock Information
- Founded
- BARK 2011
- OLMA 2006
- Country
- BARK United States
- OLMA United States
- Employees
- BARK N/A
- OLMA N/A
- Industry
- BARK Department/Specialty Retail Stores
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- OLMA Health Care
- Exchange
- BARK Nasdaq
- OLMA Nasdaq
- Market Cap
- BARK 244.9M
- OLMA 289.0M
- IPO Year
- BARK N/A
- OLMA 2020
- Fundamental
- Price
- BARK $1.16
- OLMA $4.60
- Analyst Decision
- BARK Buy
- OLMA Strong Buy
- Analyst Count
- BARK 2
- OLMA 3
- Target Price
- BARK $2.50
- OLMA $27.67
- AVG Volume (30 Days)
- BARK 550.0K
- OLMA 862.1K
- Earning Date
- BARK 06-02-2025
- OLMA 05-16-2025
- Dividend Yield
- BARK N/A
- OLMA N/A
- EPS Growth
- BARK N/A
- OLMA N/A
- EPS
- BARK N/A
- OLMA N/A
- Revenue
- BARK $490,256,000.00
- OLMA N/A
- Revenue This Year
- BARK $3.12
- OLMA N/A
- Revenue Next Year
- BARK $7.76
- OLMA N/A
- P/E Ratio
- BARK N/A
- OLMA N/A
- Revenue Growth
- BARK N/A
- OLMA N/A
- 52 Week Low
- BARK $1.09
- OLMA $2.86
- 52 Week High
- BARK $2.56
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- BARK 39.07
- OLMA 49.07
- Support Level
- BARK $1.09
- OLMA $4.35
- Resistance Level
- BARK $1.15
- OLMA $5.74
- Average True Range (ATR)
- BARK 0.05
- OLMA 0.39
- MACD
- BARK 0.01
- OLMA -0.05
- Stochastic Oscillator
- BARK 36.84
- OLMA 17.99
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.